Vaccines against rift valley fever virus
AssigneeMolecular Genetics, Inc.
InventorsMarc S. Collett, Anthony F. Purchio
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for the cloning and expression of Rift Valley Fever Virus genes in single cell host organisms. Also described are methods for culturing these novel single-cell organisms to produce Rift Valley Fever Virus gene gene products which may be formulated for use as products which may be formulated for use as immunogens in vaccines to protect against Rift Valley Fever Virus infections.
Claims88
A purified DNA sequence coding for the M portion of the Rift Valley fever virus genome as depicted in FIGS. 2a, 2b and 2c or any portion thereof coding for an immunoreactive and antigenic determinant of a Rift Valley fever virus.
Dependencies are inferred from the claim text.